From: <Saved by Microsoft Internet Explorer 5>
Subject: Non-healing peripheral ulcers * Information for physicians
Date: Thu, 25 Sep 2003 11:17:24 +0300
MIME-Version: 1.0
Content-Type: multipart/related;
	boundary="----=_NextPart_000_0025_01C38356.98ACBF70";
	type="text/html"
X-MimeOLE: Produced By Microsoft MimeOLE V6.00.2800.1165

This is a multi-part message in MIME format.

------=_NextPart_000_0025_01C38356.98ACBF70
Content-Type: text/html;
	charset="Windows-1252"
Content-Transfer-Encoding: quoted-printable
Content-Location: http://www.veins.com/info/md-info-ulcers.htm

<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<HTML><HEAD><TITLE>Non-healing peripheral ulcers * Information for =
physicians</TITLE>
<META http-equiv=3DContent-Type content=3D"text/html; =
charset=3Dwindows-1252">
<META=20
content=3D"varicose, vein, spider, veins, varicose veins, spider veins, =
vein problems, vein treatment, large veins, small veins, sclerotherapy, =
laser treatment of varicose veins, endovenous laser, injection =
sclerotherapy, non-surgical treatment of varicose veins, laser hair =
removal, diagnosis, laser, vein clinic, vein clinics, america, american, =
vein institute, American college of phlebology, Washington, Washington =
DC, Northern Virginia, Tennessee, Maryland"=20
name=3Dkeywords>
<META=20
content=3D"Varicose vein and spider vein information for doctors and =
patients. Diagnosis and treatment options. Non-surgical treatment of =
varicose veins and spider veins. Laser hair removal for all skin types." =

name=3Ddescription>
<META content=3D"MSHTML 6.00.2800.1226" name=3DGENERATOR></HEAD>
<BODY leftMargin=3D0 topMargin=3D0 MARGINHEIGHT=3D"0" MARGINWIDTH=3D"0">
<TABLE width=3D640 border=3D0>
  <TBODY>
  <TR>
    <TD>
      <TABLE cellSpacing=3D0 cellPadding=3D5 width=3D590 align=3Dleft =
border=3D0>
        <TBODY>
        <TR>
          <TD vAlign=3Dtop align=3Dleft>
            <CENTER><FONT face=3DArial size=3D4><B>Nonhealing Leg =
Ulcers</B>=20
            </FONT><BR><FONT face=3DArial size=3D2>Copyright 2001 Craig =
F. Feied,=20
            MD, FACEP, FAAEM</FONT>=20
            <HR color=3Dblue>
            </CENTER><SMALL><FONT face=3DArial><B>General=20
            Approach</B></FONT></SMALL>
            <P></P>
            <P><SMALL><FONT face=3DArial>The initial clinical history =
taken from a=20
            patient with chronic nonhealing ulcers should permit the =
clinician=20
            to focus on a fairly small group of differential diagnoses. =
A=20
            thorough physical exam will sometimes be diagnostic, and =
will almost=20
            always narrow the choices to only a few=20
            alternatives.</FONT></SMALL></P>
            <P><SMALL><FONT face=3DArial>Directed diagnostic testing =
will permit=20
            confirmation of the clinical suspicion and will provide a =
definitive=20
            diagnosis in most cases. Virtualy every cause of lower =
extremity=20
            ulceration is associated with one or more risk factors for =
venous=20
            thrombosis, and venous congestion may trigger skin breakdown =
in a=20
            patient whose underlying disease is otherwise well =
compensated. For=20
            this reason, diagnostic screening for acute venous =
thrombosis should=20
            be carried out whenever a patient presents with a painful or =

            edematous lower extremity and a new or acutely worsening =
lower=20
            extremity ulceration.</FONT></SMALL></P>
            <P><SMALL><FONT face=3DArial>Local wound care may be =
initiated based=20
            upon nothing more than the appearance and behaviour of the =
wound,=20
            but a rational and comprehensive treatment plan which =
addresses the=20
            underlying etiology of the wound requires a firm=20
            diagnosis.</FONT></SMALL></P>
            <P><SMALL><FONT face=3DArial>The differential diagnosis of =
the=20
            nonhealing ulcers is not extensive, consisting of only a few =

            categories of diseases.</FONT></SMALL>
            <UL>
              <LI><SMALL><FONT face=3DArial>Infectious =
conditions</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Malignancy</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Large vessel arterial=20
              insufficiency</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Small vessel arterial=20
              insufficiency</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Deep venous blockage or=20
              insufficiency</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Superficial venous =
insufficiency=20
              (varicose veins)</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Lymphatic =
obstruction</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Intrinsic circulatory =
insufficiency=20
              Hematologic abnormalities</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Collagen vascular=20
              disorders</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Trophic =
causes</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Miscellaneous</FONT></SMALL> =
</LI></UL>
            <P><SMALL><FONT face=3DArial>Virtually every cause of =
nonhealing=20
            ulcerations falls into one of these categories. A partial =
expansion=20
            of these categories to include the most common specific =
causes of=20
            nonhealing results in a differential list that is still=20
            manageable.</FONT></SMALL></P>
            <P><SMALL><FONT face=3DArial><B>Expanded differential list =
for=20
            nonhealing wounds</B></FONT></SMALL>
            <UL>
              <LI><SMALL><FONT face=3DArial><STRONG><U>Infectious=20
              conditions</U></STRONG></FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Treponemal/spirochetic (esp. =

              syphilitic)</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Mycobacterial (m. leprae, =
lupus=20
              vulgaris, atypical tb, tuberculids)</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Fungal (Sporotrichosis,=20
              histoplasmosis, coccidiomycosis)</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Bacterial</FONT></SMALL>=20
              <LI><SMALL><FONT=20
              =
face=3DArial><STRONG><U>Malignancy</U></STRONG></FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Basal cell (esp in =
transformation of=20
              pre-existing chronic ulcer)</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Squamous</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Kaposi's</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Lymphoma</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Mycosis =
fungoides</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial><STRONG><U>Large vessel =
arterial=20
              insufficiency</U></STRONG></FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Arteriosclerotic (including=20
              arteriosclerosis obliterans)</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Traumatic</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Thrombotic</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial><STRONG><U>Small vessel =
arterial=20
              insufficiency</U></STRONG></FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Diabetic</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Hypertensive</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Thromboangiitis=20
              obliterans</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Raynaud's &amp; livedo=20
              reticularis</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial><STRONG><U>Deep venous =
blockage or=20
              insufficiency</U></STRONG></FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Thrombotic =
obstruction</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Extrinsic =
compression</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Deep valvular insufficiency =
(esp=20
              postphlebitic)</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Superficial venous=20
              insufficiency</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Saphenofemoral=20
              insufficiency</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Saphenopopliteal=20
              insufficiency</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Perforator=20
              insufficiency</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial><STRONG><U>Lymphatic=20
              obstruction</U></STRONG></FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Venolymphatic disease (pure=20
              overload)</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Primary lymphatic =
insufficiency=20
              syndromes</FONT></SMALL>=20
              <LI><SMALL><FONT =
face=3DArial>Lymphangiosarcoma</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial><STRONG><U>Hematologic=20
              abnormalities</U></STRONG></FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Anemias (esp sickle cell=20
              disease)</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Polycythemias</FONT></SMALL> =

              <LI><SMALL><FONT =
face=3DArial>Dysproteinemias</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial><STRONG><U>Collagen vascular =

              disorders</U></STRONG></FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>SLE &amp; =
Scleroderma</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Polyarteritis =
nodosum</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Wegener's=20
              granulomatosis</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial><STRONG><U>Trophic=20
              causes</U></STRONG></FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Diabetic =
neuropathy</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Alcoholic =
neuropathy</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Decubitus</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Bone spurs</FONT></SMALL>=20
              <LI><SMALL><FONT=20
              =
face=3DArial><STRONG><U>Miscellaneous</U></STRONG></FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Pyoderma =
gangrenosum</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Gout</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Porphyria</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Ergotism</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Drug abuse</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Radiation =
necrosis</FONT></SMALL>=20
            </LI></UL>
            <P><SMALL><FONT face=3DArial>It is important to take a =
regular and=20
            organized approach to the patient with nonhealing ulcers. =
One such=20
            approach is outlined here.</FONT></SMALL></P>
            <P align=3Dleft><SMALL><FONT face=3DArial><B><I>First visit: =

            comprehensive clinical evaluation</I></B></FONT></SMALL></P>
            <OL>
              <LI><SMALL><FONT face=3DArial>History</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Physical =
examination</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Obtain prior records and =
assemble=20
              patient database</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Order routine labwork if no =
recent=20
              results are available</FONT></SMALL>
              <BLOCKQUOTE>
                <UL>
                  <LI><SMALL><FONT face=3DArial>VDRL</FONT></SMALL>=20
                  <LI><SMALL><FONT face=3DArial>CBC</FONT></SMALL>=20
                  <LI><SMALL><FONT face=3DArial>SMA-20</FONT></SMALL>=20
                  <LI><SMALL><FONT face=3DArial>Chest =
X-ray</FONT></SMALL>=20
                  <LI><SMALL><FONT face=3DArial>PPD</FONT></SMALL>=20
                  <LI><SMALL><FONT face=3DArial>X-ray of the ulcer=20
                  base</FONT></SMALL> </LI></UL></BLOCKQUOTE>
              <LI><SMALL><FONT face=3DArial>Initiate routine wound care =
based upon=20
              appearance of wound</FONT></SMALL> </LI></OL>
            <P align=3Dleft><SMALL><FONT face=3DArial><B><I>Second =
visit: further=20
            diagnostic evaluation &amp; testing as indicated, based on=20
            comprehensive clinical evaluation</I></B></FONT></SMALL></P>
            <OL>
              <LI><SMALL><FONT face=3DArial>Evaluate for large-vessel =
arterial=20
              insufficiency</FONT></SMALL>
              <UL>
                <LI><SMALL><FONT face=3DArial>Bidirectional CW=20
                doppler</FONT></SMALL>=20
                <LI><SMALL><FONT face=3DArial>Arterial (AC) =
PPG</FONT></SMALL>=20
                <LI><SMALL><FONT face=3DArial>If pulses are diminished =
and above=20
                tests are abnormal, then perform transcutaneous tissue=20
                PO2</FONT></SMALL> </LI></UL>
              <LI><SMALL><FONT face=3DArial>Evaluate for small-vessel =
arterial=20
              insufficiency</FONT></SMALL>
              <UL>
                <LI><SMALL><FONT face=3DArial>Transcutaneous tissue=20
                PO2</FONT></SMALL>=20
                <LI><SMALL><FONT face=3DArial>Laser =
doppler</FONT></SMALL>=20
</LI></UL>
              <LI><SMALL><FONT face=3DArial>Evaluate for venous outflow=20
              obstruction</FONT></SMALL>
              <UL>
                <LI><SMALL><FONT face=3DArial>Pneumoplethysmography =
(maximum=20
                venous outflow)</FONT></SMALL> </LI></UL>
              <LI><SMALL><FONT face=3DArial>Evaluate for deep and =
superficial=20
              venous valvular insufficiency</FONT></SMALL>
              <UL>
                <LI><SMALL><FONT face=3DArial>Venous (DC) =
photoplethysmography=20
                with &amp; without tourniquets to quantify reflux and to =
assess=20
                correctability</FONT></SMALL>=20
                <LI><SMALL><FONT face=3DArial>BCW doppler to identify =
the level=20
                and site of venous reflux</FONT></SMALL> </LI></UL>
              <LI><SMALL><FONT face=3DArial>Evaluate for collagen =
vascular=20
              disease, hematologic disorders, infections</FONT></SMALL>
              <UL>
                <LI><SMALL><FONT face=3DArial>FANA</FONT></SMALL>=20
                <LI><SMALL><FONT face=3DArial>RA prep</FONT></SMALL>=20
                <LI><SMALL><FONT face=3DArial>Serum =
complement</FONT></SMALL>=20
                <LI><SMALL><FONT face=3DArial>Fungal or bacterial =
cultures of the=20
                ulcer</FONT></SMALL> </LI></UL></LI></OL>
            <P><SMALL><FONT face=3DArial><B><I>Further=20
            Evaluation</I></B></FONT></SMALL></P>
            <P><SMALL><FONT face=3DArial><U>If large-vessel arterial =
disease is=20
            suspected</U></FONT></SMALL>
            <UL>
              <LI><SMALL><FONT face=3DArial>Duplex ultrasound =
exam</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Possible =
arteriography</FONT></SMALL>=20
              </LI></UL>
            <P><SMALL><FONT face=3DArial><U>If small-vessel arterial =
disease is=20
            suspected</U></FONT></SMALL>
            <UL>
              <LI><SMALL><FONT face=3DArial>Rheumatologic =
workup</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Biopsy</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Consideration for hyperbaric =
oxygen=20
              therapy</FONT></SMALL> </LI></UL>
            <P><SMALL><FONT face=3DArial><U>If venous obstruction or =
insufficiency=20
            are suspected</U></FONT></SMALL>
            <UL>
              <LI><SMALL><FONT face=3DArial>Duplex ultrasound =
exam</FONT></SMALL>=20
              </LI></UL>
            <P><SMALL><FONT face=3DArial><U>If acute deep vein =
thrombosis is=20
            proven</U></FONT></SMALL>
            <UL>
              <LI><SMALL><FONT face=3DArial>Hospital admission &amp;=20
              anticoagulation</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Hematology =
consultation</FONT></SMALL>=20

              <LI><SMALL><FONT face=3DArial>Invasive radiology =
consultation=20
              (consider intrathrombus delivery of lytic =
agent)</FONT></SMALL>=20
              </LI></UL>
            <P><SMALL><FONT face=3DArial><U>If collagen vascular disease =
or=20
            arteritis are suspected</U></FONT></SMALL>
            <UL>
              <LI><SMALL><FONT face=3DArial>Rheumatologic =
workup</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Biopsy</FONT></SMALL> =
</LI></UL>
            <P><SMALL><FONT face=3DArial><U>If infection is=20
            suspected</U></FONT></SMALL>
            <UL>
              <LI><SMALL><FONT face=3DArial>Culture &amp;=20
              sensitivity</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Quantitative tissue =
bacterial=20
              cultures</FONT></SMALL> </LI></UL>
            <P><SMALL><FONT face=3DArial><U>If poor local tissue care is =

            suspected</U></FONT></SMALL>
            <UL>
              <LI><SMALL><FONT face=3DArial>Social services &amp; home =
care=20
              arrangements</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Podiatric referral for foot=20
              care</FONT></SMALL> </LI></UL>
            <P><SMALL><FONT face=3DArial><U>If drug abuse or factitious =
ulceration=20
            are suspected</U></FONT></SMALL>
            <UL>
              <LI><SMALL><FONT face=3DArial>Psychiatric=20
              consultation</FONT></SMALL> </LI></UL>
            <P><SMALL><FONT face=3DArial><U>If hematologic abnormalities =
are=20
            suspected</U></FONT></SMALL>
            <UL>
              <LI><SMALL><FONT face=3DArial>Hematologic =
workup</FONT></SMALL>=20
            </LI></UL>
            <P><SMALL><FONT face=3DArial><U>If chronic bony =
abnormalities are=20
            suspected (trophic ulcer)</U></FONT></SMALL>
            <UL>
              <LI><SMALL><FONT face=3DArial>Podiatric or orthopedic=20
              referral</FONT></SMALL> </LI></UL>
            <P><SMALL><FONT face=3DArial><U>If the patient has=20
            osteomyelitis</U></FONT></SMALL>
            <UL>
              <LI><SMALL><FONT face=3DArial>Long-term central catheter=20
              placement</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Home infusion nurse for=20
              antibiotics</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Orthopedic =
consultation</FONT></SMALL>=20
              </LI></UL>
            <P><SMALL><FONT face=3DArial><U>If malignancy is=20
            suspected</U></FONT></SMALL>
            <UL>
              <LI><SMALL><FONT face=3DArial>Biopsy</FONT></SMALL>=20
              <LI><SMALL><FONT face=3DArial>Referral depending upon=20
              results</FONT></SMALL> </LI></UL>
            <P><SMALL><FONT face=3DArial><B><I>Therapeutic=20
            management</I></B></FONT></SMALL></P>
            <P><SMALL><FONT face=3DArial><U>Treatment =
plan</U></FONT></SMALL></P>
            <P><SMALL><FONT face=3DArial>After the initial evaluation, =
the=20
            diagnostic workup, and completion of all diagnostic =
referrals, a=20
            comprehensive treatment plan will be made. The treatment =
plan will=20
            include a plan for progressive local wound care as well as a =
plan=20
            for addressing any identifiable underlying causes which may =
be=20
            amenable to treatment. It is recognized that in many cases =
the=20
            underlying disease process may not be directly=20
            treatable.</FONT></SMALL></P>
            <P><SMALL><FONT face=3DArial><U>Ongoing =
therapy</U></FONT></SMALL></P>
            <P><SMALL><FONT face=3DArial>Routine local wound care must =
be carried=20
            out on a regular basis. Additional therapy, such as =
antibiotic=20
            therapy or hyperbaric oxygen therapy, should be added as =
indicated.=20
            Procedures to improve or correct an underlying problem must =
be=20
            undertaken whenever the underlying problem can be =
identified.=20
            Additional or repeated diagnostic evaluation will be carried =
out as=20
            needed to assess response to treatment, to evaluate a change =
in the=20
            patient's clinical condition, or to investigate newly =
suspected=20
            medical problems which are believed to cause or contribute =
to a=20
            failure of wound healing.</FONT></SMALL></P>
            <P><SMALL><FONT face=3DArial><U>Skin =
grafting</U></FONT></SMALL></P>
            <P><SMALL><FONT face=3DArial>When a large wound is clean and =

            adequately vascularized and has developed a good bed of =
granulation=20
            tissue, a plastic surgery consultation is indicated in order =
to=20
            assess the possible value of skin grafting. This often is =
not=20
            necessary, but in some cases may significantly decrease time =
off=20
            work. =
</FONT></SMALL></P></TD></TR></TBODY></TABLE></TD></TR>
  <TR>
    <TD>
      <HR color=3Dblue>

  </TD></TR></TBODY></TABLE></BODY></HTML>

------=_NextPart_000_0025_01C38356.98ACBF70
Content-Type: image/gif
Content-Transfer-Encoding: base64
Content-Location: http://www.veins.com/pix/avi-banner.gif
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------=_NextPart_000_0025_01C38356.98ACBF70--
